Meth Control Bill Amendment Would Restrict OTC Cough/Cold Sales
This article was originally published in The Tan Sheet
Executive Summary
Strict limitations on the sale of OTC cough/cold medications would result from a possible amendment to methamphetamine control legislation under consideration in the Senate.
You may also be interested in...
Methamphetamine education program for OTC retailers/wholesalers Phase II under way.
METHAMPHETAMINE NATIONAL RETAIL EDUCATION PROGRAM, sponsored by an industry coalition, is providing retailers and wholesalers with information on how to comply with the Comprehensive Methamphetamine Control Act of 1996. Signed into law in October, the act includes new restrictions on OTC drugs containing ephedrine, phenylpropanolamine (PPA) and pseudoephedrine (PSE) to help prevent the illegal manufacture and sale of methamphetamine ("The Tan Sheet" Oct. 7, 1996, p. 4). The program is in its second phase; Phase I involved a bulletin to retailers explaining the law ("The Tan Sheet" Nov. 11, 1996, p. 7).
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands